Clinical Presentations, Microbiology, Antibiotic Resistance Patterns and Management Outcomes of Culture-proven Infection Among Adolescent and Adult in A Tertiary Hospital in Saudi Arabia
NCT ID: NCT04395586
Last Updated: 2022-01-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
OBSERVATIONAL
2020-07-01
2021-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Population Pharmacokinetics and Dosage Individualization of Antibiotics in Elderly Patients
NCT04799626
PK and PD of Antibiotics for Treatment of Mycobacterium Abscessus Pulmonary Disease
NCT05676138
Role of Pseudomonas Aeruginosa Biofilms in Exacerbations in Patients With Bronchiectasis With and Without Chronic Obstructive Pulmonary Disease
NCT04803695
Pattern and Outcomes of Chest Diseases
NCT06053528
Clinical Trial for the Assessment of Delayed Antibiotic Treatment Strategies
NCT01363531
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Culture-proven infected patients
Culture
Culture
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Culture
Culture
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Able to provide a written informed consent.
Exclusion Criteria
* Unable/unwilling to provide a written informed consent.
13 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Aseer Central Hospital
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Abdullah M. Algarni
Family medicine senior registrar
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Abdullah M Algarni, MBBS
Role: PRINCIPAL_INVESTIGATOR
Aseer Central Hospital
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ACH-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.